Ecuador vs South-Eastern Asia: Proportion of the target population who received the final dose of
Ecuador
89.0%
in 2024
South-Eastern Asia
51.0%
in 2024
Ecuador rank
11th
South-Eastern Asia rank
13th
Proportion of the target population who received the final dose of over time
- Ecuador
- South-Eastern Asia
How they compare
Ecuador currently reports 89.0% against 51.0% in South-Eastern Asia, a difference of 38.0%.
That makes Ecuador's figure about 1.7 times South-Eastern Asia's.
The two have swapped places 2 times across 11 shared years of data; in 2014 it was Ecuador ahead.
Ecuador ranks 11th and South-Eastern Asia ranks 13th of 107 countries.
Ecuador has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Ecuador | South-Eastern Asia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 81.2% | 7.7% | 73.5% | Ecuador |
| 2020s | 45.8% | 19.2% | 26.6% | Ecuador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Ecuador or South-Eastern Asia?
- Ecuador, at 89.0% against 51.0% in South-Eastern Asia as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Ecuador and South-Eastern Asia?
- 38.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and South-Eastern Asia?
- 11 years are reported by both, from 2014 to 2024.
- How do Ecuador and South-Eastern Asia rank globally for proportion of the target population who received the final dose of?
- Ecuador ranks 11th and South-Eastern Asia ranks 13th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.